Drug Shortage Report for RATIO-DOCUSATE SODIUM
Report ID | 128327 |
Drug Identification Number | 00870226 |
Brand name | RATIO-DOCUSATE SODIUM |
Common or Proper name | DOCUSATE SOD 20MG/5ML SYRUP |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | DOCUSATE SODIUM |
Strength(s) | 20MG |
Dosage form(s) | SYRUP |
Route of administration | ORAL ORAL |
Packaging size | 500ml |
ATC code | A06AA |
ATC description | DRUGS FOR CONSTIPATION |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2020-11-11 |
Estimated end date | 2021-01-31 |
Actual end date | 2021-01-20 |
Shortage status | Resolved |
Updated date | 2021-01-21 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v6 | 2021-01-21 | French | Compare |
v5 | 2021-01-21 | English | Compare |
v4 | 2021-01-07 | French | Compare |
v3 | 2021-01-07 | English | Compare |
v2 | 2020-11-12 | French | Compare |
v1 | 2020-11-12 | English | Compare |
Showing 1 to 6 of 6